|
Barbara, Lapatinib (Tykerb) is what's known as a tyrosine kinase inhibitor; there's another one in trials now called Tarceva. I posted a link on a Phase II trial of Tarceva on the clinical trials page just now. However, the criteria specifies MBC patients. But you might want to look at it anyway as the study details are interesting and perhaps later trials will include earlier stage volunteers. Worth checking out.
<3 Lolly
|